Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim: To asess ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

Background and Aim: To investigate the participation rates, positivity rates, and follow-up rates from 2004 to 2008 in an organized colorectal cancer (CRC) screening program using a fecal occult blood ...

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

Routine screening with fecal occult blood testing (FOBT) is associated with a decrease in colorectal cancer (CRC) mortality, according to a study published online Feb. 27 in JAMA Network Open.

The inexpensive tests that look for hidden blood in a person's stool are effective for colon cancer screening, a study confirms. The findings, reported in the Canadian Medical Association Journal, ...

Nothing elicits a groan from patients as quickly as discussion of uncomfortable screening procedures. Yet those discussions must take place. Colorectal cancer is the third-most common cancer in the ...

More than 75 percent of primary care physicians in the United States who order or perform the fecal occult blood test as a screening option for colorectal cancer perform an in-office test rather than ...

The introduction of biennial colorectal cancer screening in a region of France increased the rate of diagnosis of high risk pre-cancerous adenomas (sometimes called polyps) by 89%, researchers have ...